Related Experiment Video
Updated: Apr 16, 2026
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Statin treatment in primary and secondary prevention--a statement]
Insights
Statin therapy effectively lowers LDL cholesterol, reducing cardiovascular event risk, especially in high-risk asymptomatic individuals. Lifestyle changes are recommended for low-risk patients.
Area of Science:
- Cardiology
- Pharmacology
- Preventive Medicine
Context:
- Lipid-lowering therapy, particularly statins, is standard for secondary cardiovascular prevention.
- Debate exists regarding statin efficacy in asymptomatic individuals (primary prevention).
- Treatment discontinuation is observed, especially in French- and Italian-speaking regions of Switzerland.
Purpose:
- To clarify the role of statin therapy in primary cardiovascular prevention.
- To emphasize the importance of risk stratification for statin initiation.
- To guide treatment decisions based on individual cardiovascular risk.
Summary:
- Statins reduce LDL cholesterol, thereby decreasing cardiovascular event risk in primary prevention.
- The absolute benefit of statins is greater in individuals with higher baseline cardiovascular risk.
- Risk assessment tools are crucial for identifying appropriate candidates for statin therapy.
Impact:
- Informs clinical practice regarding statin use in primary prevention.
- Highlights the need for personalized cardiovascular risk assessment.
- Supports lifestyle interventions for low-risk populations, optimizing resource allocation.
Abstract:
Although lipid-lowering therapy in patients with established coronary heart disease (secondary prevention) is generally accepted, its benefit is often questioned in asympto- matic patients. The ongoing debate about the usefulness of statin therapy has disturbed many patients, especially in the French- and Italian-speaking parts of Switzerland, which lead too often to treatment discontinuation, even in patients who would benefit the most from it. In the primary prevention, the reduction in LDL cholesterol levels with statins decreases the risk for cardiovascular events. The higher the baseline risk, the greater the benefits in terms of absolute risk reduction; hence, using a scoring tool to evaluate the cardiovascular risk is needed. For patients at low risk, lifestyle interventions are preferable.
More Related Videos
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017